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Abstract
Objective—To conduct a longitudinal evaluation of PROMIS® Social Function measures 
(Satisfaction with Participation in Social Roles, and Satisfaction with Participation in 
Discretionary Social Activities) in English-speaking people with chronic health conditions.
Study Design and Setting—Adults receiving treatment for chronic heart failure (CHF), 
chronic obstructive pulmonary disease (COPD), chronic back pain, or depression completed 
PROMIS computer-based measures of social health at two time points approximately three months 
apart, and global ratings of change. Linear mixed effects models and standardized response means 
were estimated for the two social function measures.
Results—A total of 599 people participated: 79 with stable COPD, 46 COPD exacerbation, 60 
with CHF, 196 with depression and 218 with back pain. Four groups experienced improvement 
over time; one (COPD-stable) changed very little. Those who reported better global ratings of 
change in overall health experienced larger changes in social function than those who reported the 
same or worse global health.
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Conclusion—This study provided support for responsiveness to change for two PROMIS social 
function measures. These results provide further evidence of the PROMIS goal to enable 
comparable measurement of universally relevant symptoms and experiences that apply to people 
with a variety of diseases.
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INTRODUCTION
While social health has long been recognized as an integral component of health1, it has 
received limited attention in clinical practice and medical research. The World Health 
Organization’s International Classification of Functioning, Disability and Health (ICF) has 
helped to highlight social participation as both a determinant of health2–4 and as a treatment 
outcome valued by patients, providers and policy makers.5 Participation in social roles and 
discretionary activities is included in the ICF’s core sets for chronic heart failure (CHF), 
chronic obstructive pulmonary disease (COPD), back pain and depression.6–8 The 
importance of social participation in chronic medical conditions such as these is well 
documented.9–14 There is, however, a need for standardized measures of social health and 
participation that are applicable to a broad range of conditions and clinical settings.15 The 
initiative titled PROMIS® (Patient-Reported Outcomes Measurement Information System) 
developed measures of social role performance and participation that are intended to be 
universally relevant, rather than disease-specific. That is, the measures are assumed relevant 
across many clinical populations and levels of severity, allowing for broad applicability and 
comparability across populations and diseases.
The PROMIS Social Health workgroup developed Social Function measures using a mixed-
methods approach that included cognitive interviews, focus groups and large-scale cross-
sectional testing with a general population sample.16–20 Social Function is defined as 
involvement in, and satisfaction with, one’s usual roles in life’s situations and activities. 
These roles may exist in marital relationships, family responsibilities, work/school 
responsibilities and social activities. Item response theory methods were used to create 
computer adaptive tests (CAT) and fixed-length short forms.21–24 This manuscript describes 
the longitudinal evaluation of two PROMIS Social Function CAT measures (Satisfaction 
with Participation in Social Roles and Satisfaction with Participation in Discretionary Social 
Activities) in five English-speaking clinical samples.
METHODS
Participant recruitment and assessment procedures
Five patient samples were included in four studies (COPD, CHF, Back Pain, Depression) 
that assessed social function. Participant recruitment procedures are described in the 
overview paper (Cook et al., this volume).25 All participants received some type of treatment 
for their condition; specifically, COPD and Depression participants received treatment 
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appropriate for their level of disease, CHF participants received a heart transplant, and Back 
Pain participants received spinal injections.
Version 1.0 of the PROMIS Social Function measures includes 14 Satisfaction with 
Participation in Social Roles items and 12 Satisfaction with Participation in Discretionary 
Social Activities items. These measures refer to social roles such as work and family 
responsibilities, and more discretionary social activities such as leisure activity and 
relationships with friends. Most participants completed a CAT for both measures; CHF 
participants completed only one CAT (Discretionary Social Activities). Although some 
participants completed multiple longitudinal assessments, only two were selected for this 
analysis: baseline and one follow-up (at approximately three months). An assessment was 
scheduled at three months for most studies because some degree of clinical change was 
expected to have occurred by that point. For the CHF study, multiple follow-up assessments 
occurred after heart transplantation. The 10-week assessment was chosen for this analysis 
because it was closest to three months. Investigators predicted a large magnitude of 
improvement in both social roles and discretionary social activities for patients who were 
recovering from exacerbation of their COPD. They also predicted a large improvement in 
discretionary social activities for CHF patients after their heart transplant. Participants in the 
Pain and Depression groups were expected to improve in Social Function, although 
investigators did not have predictions about whether improvement would differ across the 
two aspects of Social Function (social roles vs. discretionary social activities). Participants 
also completed a global rating of change at the follow-up assessment.26 They reported the 
amount of change in their overall health using a seven-point scale (very much worse, 
moderately worse, a little worse, about the same, a little better, moderately better, very much 
better). The three “better” categories and the three “worse” categories were combined to 
create three overall change groups: better, about the same, worse. Social function-specific 
change was also assessed for some participants. CHF participants reported change in their 
ability to carry out usual social activities and roles since their heart transplant; similar 
overall change groups were created as described above. COPD participants completed the 
PROMIS Global Health instrument. 27 Change groups were then calculated using the change 
from baseline to follow-up in responses to the PROMIS Global question: “In general, how 
would you rate your satisfaction with your social activities and relationships?” Some 
participants did not complete the global rating of change of the PROMIS Global Health 
instrument. Subsample sizes for each of the change groups are listed under the standardized 
response means in Tables 2 and 3.
Statistical analyses
Analyses to evaluate responsiveness (sensitivity to change) were conducted separately for 
each of five clinical groups: stable COPD, exacerbating COPD, CHF, back pain and 
depression. The first set of analyses evaluated change from baseline to follow-up. Linear 
mixed models were estimated with random subject effects to account for the correlation 
among repeated observations within individuals.28,29 Missing data were evaluated prior to 
performing longitudinal analyses; this included a comparison of baseline characteristics 
between participants with and without complete data. Assuming data were missing at 
random (MAR), the analyses included respondents with data at either time point.30,31 Least 
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squares means, standard errors and 95% confidence intervals were estimated from the 
models.
The second set of analyses evaluated change in the PROMIS measures in relation to 
participants’ self-reported change. Only participants with data at both time points and with a 
response to the self-reported change item were included in these analyses. Change scores in 
the CAT measures were used to estimate the standardized response mean for each of the 
three change groups: the ratio of the mean change to the standard deviation of that change.32 
This is a form of Cohen’s effect size index.33 An effect size of 0.30 is generally considered 
as a useful criterion for a minimally important difference in patient-reported outcome 
measures.34
RESULTS
Participant characteristics
A total of 599 people participated in the clinical studies that assessed Social Function. 
Participants were diverse in terms of gender, age, and marital status (see Table 2 in the 
overview paper; Cook et al., this issue).25 Most participants were non-Hispanic Whites and 
had some college education. Most participants had moderate to severe health limitations. 
Study dropout was 4% for participants in the COPD and Depression groups, 16% for CHF, 
and 21% for Pain. Comparison of baseline characteristics between participants with and 
without complete data suggested some differences, indicating that missing data are not 
missing completely at random (MCAR).30,31
Responsiveness
The results of the mixed models for the PROMIS Social Function measures are summarized 
in Table 1. Least squares means at baseline and follow-up are shown in Figure 1. Four of the 
clinical groups experienced statistically significant (p<0.05) improvement in Satisfaction 
with Participation in Discretionary Social Activities over time, with estimated mean change 
scores ranging from 2.6 to 9.5. One clinical group (COPD-stable) changed very little over 
time.
For most participants who reported that their global or overall health changed for the better, 
there was a corresponding medium to large improvement in Social Function over time 
(standardized response means ranged from 0.43 to 0.88; see Table 2). One endpoint for one 
clinical group showed a smaller effect (0.19 for Social Roles among COPD-Exacerbation). 
Effect sizes for those who reported better overall health were nearly always larger than effect 
sizes for those who reported the same or worse overall health. However, many effect sizes 
for the latter groups were also positive, suggesting improved social function overall. Mean 
change scores are also shown in Table 2. Responsiveness to domain-specific (social 
activities) change exhibited some of the similar trends, i.e., larger improvement for those 
who reported better health, but improvement also for those with the same or worse health 
(Table 3).
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DISCUSSION
PROMIS includes several measures of social function and social relationships that have 
undergone rigorous psychometric assessment and evolution, demonstrated strong properties, 
and are publically available in English and Spanish for use in research and clinical practice 
(www.assessmentcenter.net).19,35 The present study expanded validation efforts by 
conducting longitudinal evaluations of two PROMIS Social Function measures (Satisfaction 
with Participation in Social Roles and Satisfaction with Participation in Discretionary Social 
Activities).
Longitudinal studies with 599 people with chronic conditions (stable COPD, exacerbating 
COPD, CHF, back pain and depression) demonstrated the responsiveness to change of these 
two PROMIS Social Function CAT measures. The follow-up assessments were scheduled to 
represent sufficient time for the individuals to experience improvement in their health. These 
results provide further evidence of the PROMIS goal to enable comparability of experiences 
across diseases through measurement of common, generic symptoms and experiences that 
apply to people in a variety of contexts or with a variety of diseases.36
If aspects of social health are to be included in clinical research and practice as outcomes, 
not just determinants, the ability of relevant measures to detect change over time must be 
established. Responsiveness (sensitivity to change) is emphasized within guidelines for 
evaluating the reliability and validity of patient-reported outcome measures.37,38 Ideally, a 
measure of social health demonstrates sensitivity to both improvements and deteriorations in 
status across the entire range of the sub-domain being assessed, while not evidencing 
variability in scores due to factors not associated with true changes in status.
In this study, all but the stable COPD sample experienced improvement in Social Function 
over time, as hypothesized, and most participants who reported improved overall health also 
reported a corresponding improvement in Social Function over time. Effect sizes for those 
who reported better overall health were nearly always larger than effect sizes for those who 
reported the same or worse overall health. However, many effect sizes for the latter groups 
were also positive, indicating improved Social Function. These results suggest that 
satisfaction with social functioning may not decline among people who view their overall 
health as worsened. Social function may be influenced by factors other than health status, 
particularly among people who experience worsening in their health.3940 For example, 
people whose health declines may experience an improvement in family and other social 
support, or more closeness with loved ones, thereby increasing their satisfaction with social 
functioning. In addition, adaptation to worsening health might lead to a change in 
perspective about one’s social role that is reflected in unchanged or even improved 
satisfaction.
Prior to initiating the COPD study, researchers agreed on predictions of large improvement 
for patients who were recovering from exacerbation of their COPD. For social health, these 
predictions were based mostly on analysis of the item content and prior research on the 
change in general health-related quality of life and physical function. The research team 
predicted a large magnitude of change for both social roles and discretionary social 
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activities. As reported here, small to moderate effect sizes were observed. This may be 
related to the acute changes associated with COPD exacerbation. Even during exacerbation, 
respondents may take into account their social function relative to their usual state. As 
expected, there was little change in social function for COPD patients enrolled and followed 
while stable. Also as expected, patients experienced a large improvement in social function 
after their heart transplant. For the Pain patient group, improvements were seen in both 
measures of social function.
In the area of mental health, increased emphasis on patient-centered research and practice 
has led to greater attention to “recovery” and factors that help produce improved functioning 
and quality of life. Previous clinical trials have often focused on short-term improvements in 
acute symptoms and clinical status. Such changes are important but may not be sufficient for 
patients who remain distressed by impairment in social and role functioning. Our results 
here for depressed outpatients are encouraging and consistent with the trend toward 
increased emphasis on “real-life” functioning. The PROMIS measures for social 
participation are brief, valid, and efficient tools for assessing social functioning and 
monitoring its improvement during the course of treatment.
There are some limitations to this project. All of the studies used v1.0 of the PROMIS Social 
Function measures. There is now a newer version (v2.0) with more items and a different 
domain structure. However, all of the v1.0 items are included in v2.0 Satisfaction with 
Social Roles and Activities, suggesting that these results can be carried forward into v2.0. 
(See online Appendix for details.) The measures used with the current clinical samples were 
not very sensitive to self-reported deterioration. This may reflect the possibility that through 
personal adaptation or positive change in the social milieu, satisfaction with social function 
does not worsen as health status declines. It is also possible that the use of a global rating of 
change as a meaningful anchor is flawed. Although these change measures have been used 
for over 20 years, there is some concern about their reliability and validity.41 Another 
possibility is that the PROMIS Social Function measures are not sensitive to change. There 
were some missing data in this study, and the analyses were conducted assuming the data 
were missing at random (MAR). It is not possible to test for the appropriateness of the MAR 
assumption compared to missing not at random (MNAR).30,31 The MAR assumption, 
conditional on the observed data, seems reasonable in this setting and is also appropriate for 
MCAR data.
This longitudinal study expands the body of evidence for the validity of two PROMIS social 
function measures by establishing that they are sensitive to clinical change/changes in health 
status. This suggests that they can be used in longitudinal observational and intervention 
research, alongside measures of physical and mental health, to provide a more 
comprehensive assessment of the impact of chronic disease on patients. These findings will 
also inform sample size estimation for studies to evaluate the impact of interventions on 
satisfaction with participation. In summary, the PROMIS Satisfaction with Social 
Participation item banks have demonstrated that they can be used as accurate measures of 
social function across a range of chronic medical conditions.
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What is new?
Key Findings
• PROMIS measures of Satisfaction with Social Participation demonstrate 
responsiveness to change in people with diverse chronic conditions.
What this adds to what was known?
• Evidence for responsiveness to change will enable social function to be included 
in clinical practice and comparative effectiveness research as an outcome, not 
just a determinant of health.
What is the implication and what should change now?
• PROMIS measures provide researchers and clinicians with the tools to 
accurately measure social function – an important but under-represented domain 
of health.
• Computer-adaptive tests and fixed-length short forms for social function are 
publicly available (www.assessmentcenter.net). Custom short forms can be 
designed and scored using PROMIS item response theory calibrations.
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Figure 1. 
PROMIS Satisfaction with Social Participation in Different Clinical Groups over Time
Higher scores indicate more satisfaction with participation. A T-score of 50 reflects the 
mean (and 10 the standard deviation) in the US general population sample that was used to 
center the T-scores.42 Abbreviations: COPD, chronic obstructive pulmonary disease; CHF, 
chronic heart failure.
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